51³Ô¹ÏºÚÁÏ

The National Institute of General Medical Sciences (NIGMS) of The National Institutes of Health (NIH) has awarded a grant expected to total $11.3 million to fund phase 2 of southern Nevada’s first Center of Biomedical Research Excellence (COBRE): The Center for Neurodegeneration and Translational Neuroscience (CNTN). The funding will allow for an additional five years of continued collaboration between Cleveland Clinic Lou Ruvo Center for Brain Health and the University of Nevada, Las Vegas (51³Ô¹ÏºÚÁÏ) to enhance neuroscience research infrastructure in southern Nevada. The award is co-led by Aaron Ritter, M.D., of the Lou Ruvo Center for Brain Health and Jefferson Kinney, Ph.D. of the Department of Brain Health at 51³Ô¹ÏºÚÁÏ.

51³Ô¹ÏºÚÁÏ and the Cleveland Clinic Lou Ruvo Center for Brain Health have received an $11.3 million federal grant for the next phase of their joint research into the causes of degenerative brain diseases such as Alzheimer’s and potential treatments.

More than 1100 people filled the Las Vegas Ballpark Saturday morning for the annual Alzheimer’s Association Walk to End Alzheimer’s.

BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that it will host a key opinion leader webinar on neuroinflammation and insulin resistance and new treatment approaches for Alzheimer’s Disease on Tuesday, October 26, 2021 at 1:30 pm Eastern Time.

51³Ô¹ÏºÚÁÏ is leading the way towards an eventual cure for Alzheimer’s with groundbreaking research.

Researchers at 51³Ô¹ÏºÚÁÏ say they’ve strengthened the link between Type II diabetes and Alzheimer’s disease, which saps brain function and has no cure.

A team of neuroscientists from 51³Ô¹ÏºÚÁÏ has confirmed the link between type 2 diabetes and Alzheimer's disease (AD) in a recent study published in the journal Communications Biology.

tudy shows chronic hyperglycemia impairs working memory performance and alters fundamental aspects of working memory brain networks. The findings strengthen the link between type 2 diabetes and Alzheimer’s disease.